Polyclonal Serum Free Light Chains: A Biomarker of Disease Prognosis or of Immune Senescence? Reply

被引：0
|
作者：
Pardanani, Animesh [1 ]
Tefferi, Ayalew [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 24期
关键词：
D O I：
10.1200/JCO.2012.44.3176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3034 / 3034
页数：1
相关论文
共 50 条
  • [21] Serum free light chains
    Forsyth, Julia
    Hill, Peter
    ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 444 - 445
  • [22] SERUM FREE LIGHT CHAINS: A NOVEL BIOMARKER IN PRE-ECLAMPSIA (PET)
    Sarween, Nadia
    Knox, Ellen
    Day, Clara
    Assi, Lakhvir
    Burmeister, Anne
    Harding, Stephen
    Cockwell, Paul
    Drayson, Mark
    Lipkin, Graham
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [23] Air Pollution and Polyclonal Elevation of Serum Free Light Chains: An Assessment of Adaptive Immune Responses in the Prospective Heinz Nixdorf Recall Study
    Ohlwein, Simone
    Hennig, Frauke
    Lucht, Sarah
    Schmidt, Boerge
    Eisele, Lewin
    Arendt, Marina
    Duehrsen, Ulrich
    Duerig, Jan
    Joeckel, Karl-Heinz
    Moebus, Susanne
    Hoffmann, Barbara
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2021, 129 (02) : 1 - 11
  • [24] Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia (cll) Prognosis
    Sarris, Katerina
    Bartzis, Vassiliki
    Maltezas, Dimitris
    Koulieris, Efstathios
    Tzenou, Tatiana
    Sachanas, Sotirios P.
    Nikolaou, Eftychia
    Efthymiou, Anna
    Bitsani, Katerina
    Dimou, Maria
    Vassilakopoulos, Theodoros
    Siakantaris, Marina
    Angelopoulou, Maria K.
    Kontopidou, Flora
    Tsaftaridis, Panagiotis
    Kafasi, Nikolitsa
    Pangalis, Gerassimos A.
    Panayiotidis, Panayiotis
    Harding, Stephen
    Kyrtsonis, Marie-Christine
    BLOOD, 2012, 120 (21)
  • [25] Serum free light chains in the differential diagnosis and prognosis of primary and secondary hypogammaglobulinemia
    Compagno, Nicolo
    Cinetto, Francesco
    Boscaro, Elisa
    Semenzato, Gianpietro
    Agostini, Carlo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (04) : 1075 - 1077
  • [26] Serum free light chains in systemic lupus erythematosus disease
    Krir, Dhouha
    Galai, Yousr
    Zamali, Imen
    Ben Hmid, Ahlem
    Rekik, Raja
    Khanfir, Monia
    Fazaa, Alia
    Houman, Habib
    Laatar, Ahmed
    Bousslema, Kamel
    Ben Ahmed, Melika
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 924 - 924
  • [27] Free light chains: Eclectic multipurpose biomarker
    Basile, Umberto
    Gulli, Francesca
    Gragnani, Laura
    Napodano, Cecilia
    Pocino, Krizia
    Rapaccini, Gian Ludovico
    Mussap, Michele
    Zignego, Anna Linda
    JOURNAL OF IMMUNOLOGICAL METHODS, 2017, 451 : 11 - 19
  • [28] Polyclonal serum free light chains levels are associated with carotid atherosclerosis in type 2 diabetes mellitus
    Tripolt, Norbert
    Zedler, Julian
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 : S143 - S143
  • [29] PROGNOSTIC VALUE OF ELEVATED POLYCLONAL SERUM FREE LIGHT CHAINS IN STAGE A CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS
    Pratt, G.
    Young, P.
    Levoguer, A.
    Pepper, C.
    Fegan, C.
    Oscier, D.
    Mead, G.
    Harding, S.
    ANNALS OF ONCOLOGY, 2011, 22 : 171 - 171
  • [30] Free light chains are a biomarker for cardiovascular disease in patients with Type 1 diabetes
    Quinn, L. M.
    McWilliam, S.
    Campbell, J. P.
    Hughes, D. S.
    Drayson, M. T.
    Narendran, P.
    DIABETIC MEDICINE, 2015, 32 : 84 - 84
12345